argenx SE virtual R&D Day Call Transcript
Good morning, and thank you to everyone for joining us today for our virtual R&D Day. I'm Beth DelGiacco, Vice President of Corporate Communications and Investor Relations at argenx. We're looking forward to a time soon when we can meet again in person.
We decided to use the virtual forum to our advantage and invited several of our argenx scientists to speak today, likely team members that you haven't met before but who are the beating heart of the company. They work closely with our molecules, our collaborators and our clinical teams and drive the ongoing translational studies to better understand the results we're seeing clinically.
On our agenda, you can see the depth of expertise of the speakers joining us today. Tim Van Hauwermeiren, our Chief Executive Officer and Co-Founder, will talk about where we are today as a company and how we are advancing towards argenx 2025. Hans de Haard, our Chief Scientific Officer and Co-Founder, will talk about efgartigimod and the translational work we've done more recently on our Fc fragment. We'll then
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
